These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18182584)

  • 1. Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.
    Flotho C; Kratz CP; Bergsträsser E; Hasle H; Starý J; Trebo M; van den Heuvel-Eibrink MM; Wójcik D; Zecca M; Locatelli F; Niemeyer CM;
    Blood; 2008 Jan; 111(2):966-7; author reply 967-8. PubMed ID: 18182584
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.
    Matsuda K; Shimada A; Yoshida N; Ogawa A; Watanabe A; Yajima S; Iizuka S; Koike K; Yanai F; Kawasaki K; Yanagimachi M; Kikuchi A; Ohtsuka Y; Hidaka E; Yamauchi K; Tanaka M; Yanagisawa R; Nakazawa Y; Shiohara M; Manabe A; Kojima S; Koike K
    Blood; 2007 Jun; 109(12):5477-80. PubMed ID: 17332249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
    Geissler K; Jäger E; Barna A; Gurbisz M; Graf T; Graf E; Nösslinger T; Pfeilstöcker M; Tüchler H; Sliwa T; Keil F; Geissler C; Heibl S; Thaler J; Machherndl-Spandl S; Zach O; Weltermann A; Bettelheim P; Stauder R; Zebisch A; Sill H; Schwarzinger I; Schneeweiss B; Öhler L; Ulsperger E; Kusec R; Germing U; Sperr WR; Knöbl P; Jäger U; Hörmann G; Valent P
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML).
    Flotho C; Valcamonica S; Mach-Pascual S; Schmahl G; Corral L; Ritterbach J; Hasle H; Aricò M; Biondi A; Niemeyer CM
    Leukemia; 1999 Jan; 13(1):32-7. PubMed ID: 10049057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.
    Schubbert S; Lieuw K; Rowe SL; Lee CM; Li X; Loh ML; Clapp DW; Shannon KM
    Blood; 2005 Jul; 106(1):311-7. PubMed ID: 15761018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome.
    Fukuda M; Horibe K; Miyajima Y; Matsumoto K; Nagashima M
    J Pediatr Hematol Oncol; 1997; 19(2):177-9. PubMed ID: 9149755
    [No Abstract]   [Full Text] [Related]  

  • 8. JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia.
    Zecca M; Bergamaschi G; Kratz C; Bergsträsser E; Danesino C; De Filippi P; Hasle H; Lisini D; Locatelli F; Pession A; Sainati L; Starý J; Trebo M; van den Heuvel-Eibrink M; Wójcik D; Niemeyer CM
    Leukemia; 2007 Feb; 21(2):367-9. PubMed ID: 17151700
    [No Abstract]   [Full Text] [Related]  

  • 9. Juvenile myelomonocytic leukemia.
    Emanuel PD
    Curr Hematol Rep; 2004 May; 3(3):203-9. PubMed ID: 15087069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the
    Patnaik MM; Pophali PA; Lasho TL; Finke CM; Horna P; Ketterling RP; Gangat N; Mangaonkar AA; Pardanani A; Tefferi A
    Haematologica; 2019 Jun; 104(6):e236-e239. PubMed ID: 30606787
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors.
    Geissler K; Jäger E; Barna A; Alendar T; Ljubuncic E; Sliwa T; Valent P
    Leukemia; 2016 Nov; 30(11):2280-2281. PubMed ID: 27585952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Xanthogranuloma, type I neurofibromatosis and myelomonocytic leukemia with spontaneous regression].
    Dehen L; Zeller J; Cosnes A; Bernaudin F; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1990; 117(11):812-4. PubMed ID: 2129184
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.
    Ohtsuka Y; Manabe A; Kawasaki H; Hasegawa D; Zaike Y; Watanabe S; Tanizawa T; Nakahata T; Tsuji K
    Blood; 2005 Nov; 106(9):3134-41. PubMed ID: 16046524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotinidase deficiency and juvenile myelomonocytic leukemia in a Turkish infant of consanguineous parents.
    Yetgin S; Aytac S; Kalkanoglu S; Coskun T; Ortmann C; Kratz C; Niemeyer C
    Pediatr Hematol Oncol; 2007 Sep; 24(6):453-5. PubMed ID: 17710663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile myelomonocytic leukemia in a child with Crohn disease.
    Oliver JW; Farnsworth B; Tonk VS
    Cancer Genet Cytogenet; 2006 May; 167(1):70-3. PubMed ID: 16682290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
    Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
    Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice.
    Parikh C; Subrahmanyam R; Ren R
    Blood; 2006 Oct; 108(7):2349-57. PubMed ID: 16763213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolutionary perspective on chronic myelomonocytic leukemia.
    Itzykson R; Solary E
    Leukemia; 2013 Jul; 27(7):1441-50. PubMed ID: 23558522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
    Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.